1. "Body Imaging Service"
Formats
  1. Journal Article (1718)
  2. Meeting Abstract (519)
  3. Review (163)
  4. Book Section (128)
  5. Conference Paper (43)
  6. Editorial (35)
  7. Guidelines (29)
  8. Miscellaneous (16)
  9. Correspondence (11)
  10. Book Whole (5)
  11. Research Letter (4)
Groups
  1. Body Imaging Service (2671)
  2. Radiology, Department of (2670)
  3. Department of Medicine (992)
  4. Solid Tumor Oncology Division (875)
  5. Surgery (752)
  6. Epidemiology and Biostatistics (734)

More Groups

People
  1. Lawrence Schwartz (306)
  2. Oguz Akin (264)
  3. Kinh Gian Do (256)
  4. Michelle Ginsberg (235)
  5. Marc Gollub (208)
  6. Hedvig Hricak (158)

More People

Years
  1. 2025 (69)
  2. 2024 (169)
  3. 2023 (220)
  4. 2022 (200)
  5. 2021 (189)
  6. 2020 (165)

More Years

Publications
  1. Journal of Clinical Oncology (322)
  2. American Journal of Roentgenology (147)
  3. Radiology (122)
  4. Abdominal Radiology (84)
  5. European Radiology (67)
  6. Clinical Cancer Research (65)

More Publications

Publishers
  1. Springer (359)
  2. American Society of Clinical Oncology (346)
  3. Elsevier Inc. (316)
  4. American Roentgen Ray Society (147)
  5. Radiological Society of North America, Inc. (141)
  6. Elsevier Science, Inc. (128)

More Publishers

Results (2671)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT
    Meeting Abstract

    Carvajal, R. D.; Chapman, P. B.; Wolchok, J. D.; Cane, L.; Teitcher, J. B.; Lutzky, J.; Pavlick, A. C.; Bastian, B. C.; Antonescu, C. R.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Rituximab, cyclophosphamide, bortezomib and prednisone (R-CBorP): Final results of a phase I trial evaluating two dosing schedules and the safety of overlapping pegfilgrastim in patients with relapsed/refractory indolent and mantle cell lymphomas
    Meeting Abstract

    Gerecitano, J.; Portlock, C. S.; Hamlin, P. A.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Schulman, P.; Dumitrescu, O.; Sarasohn, D.; Pappanicholaou, J.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • The prognostic value of residual FDG-avidity prior to allogeneic stem cell transplantation for lymphoma
    Meeting Abstract

    Sauter, C. S.; Barker, J. N.; Zelenetz, A. D.; Fleming, S. E.; Castro-Malaspina, H.; Moskowitz, C. H.
    Blood (2009)

    Fulltext@MSK | Save
  • Magnetic resonance imaging of prostate cancer
    Book Section

    Akin, O.
    In Hricak, H.; Scardino, P. T.; Reznek, R. H. (Eds.) Prostate Cancer (2009)

    Fulltext@MSK | Save
  • Systemic therapy
    Book Section

    Schwartz, L. H.; Morris, M. J.
    In Hricak, H.; Scardino, P. T.; Reznek, R. H. (Eds.) Prostate Cancer (2009)

    Fulltext@MSK | Save
  • A pilot study comparing computerized volume measurement with diameter measurement as an early biomarker of the biologic activity of EGFR targeted therapy
    Meeting Abstract

    Zhao, B. S.; Oxnard, G. R.; Guo, P. Z.; Rizvi, N. A.; Kris, M. G.; Schwartz, L. H.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Measurement of tumor volumes in patients with malignant pleural mesothelioma (MPM) correlates with prognosis
    Meeting Abstract

    Zhao, B. S.; Krug, L. M.; Liu, F.; Guo, P.; Ishill, N. M.; Moskowitz, C. S.; Rusch, V. W.; Flores, R. M.; Schwartz, L. H.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Geneus, S.; Godfrey, L.; Norton, L.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Androgen receptor inhibition can stabilize disease in patients with AR(+), ER(-)/PR(-) metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Feigin, K.; Patil, S.; Yuan, J.; Dickler, M.; Andrea, G. D.; Bromberg, J.; Hudis, C.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Phase 1 trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Meeting Abstract

    Riely, G. J.; Janjigian, Y. Y.; Pereira, L. K.; Azzoli, C. G.; Pietanza, M. C.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; more...
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save